A review of clozapine safety

Author： Fitzsimons Joanna Berk Michael Lambert Timothy Bourin Michel Dodd Seetal

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.4, Iss.4, 2005-07, pp. : 731-744

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacoeconomics of Clozapine, Risperidone and Olanzapine: A Review of the Literature

By Procyshyn R.M.

CNS Drugs, Vol. 13, Iss. 1, 2000-01 ,pp. : 47-76

Adis International

Access to resources Recommend Favorite

Clozapine-Associated Myocarditis: A Review of 116 Cases of Suspected Myocarditis Associated with the Use of Clozapine in Australia During 1993-2003

By Haas Steven J. Hill Richard

Drug Safety, Vol. 30, Iss. 1, 2007-01 ,pp. : 47-57

Adis International

Access to resources Recommend Favorite

Clozapine-Induced Obsessive-Compulsive Symptoms in Schizophrenia: A Critical Review

Current Neuropharmacology, Vol. 10, Iss. 1, 2012-03 ,pp. : 88-95

Bentham Science Publishers

Access to resources Recommend Favorite

Safety of mirtazapine: a review

By Montgomery S.A.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 263-264

Elsevier

Access to resources Recommend Favorite

Zanamivir: A Review of Clinical Safety

By Freund B.

Drug Safety, Vol. 21, Iss. 4, 1999-10 ,pp. : 267-281

Adis International

Access to resources Recommend Favorite